Michael D. Poole, M.D., Ph. D., F.A.C.S.

See Dr. Poole's Publications & Articles

• Undergraduate and Graduate Education:

• 1981 - 1988 University of North Carolina, Dept. of Microbiology Ph.D., Microbiology
• 1977 – 1981 University of North Carolina School of Medicine M.D.
• 1975 - 1978 University of North Carolina - Charlotte M.Sc. Biology, Thesis: "Pathogenicity of Vibrio vulnificus"
• 1974 - 1975 Fayetteville State University, Fort Bragg Campus B.A. History
• 1969 - 1971 Auburn University

Postgraduate Training:

• 1982 - 1986 University of North Carolina, School of Medicine Resident, Otolaryngology
• 1981 - 1982 University of North Carolina, School of Medicine Intern, General Surgery

Prior Academic Appointments:

• Professor and Interim Chairman, Dept. of Otolaryngology, University of Texas Medical School at Houston, 10/99-11/00
• Professor , Dept. of Otolaryngology and Pediatrics, University of Texas Medical School at Houston, 5/96-9/99
• Associate Professor, Departments of Otolaryngology and Pediatrics, University of Florida School of Medicine (Gainesville) 7/94 - 4/96

Licensure:

1996 - present Licensed Physician, State of Texas

Certifications:

• 1986 - present Board Certification - American Board of Otolaryngology
• 1987 - 1991 American Trauma Life Support Certification
• 1992 - 1994 Advanced Cardiac Life Support
• 1992 - Fellow, American College of Surgeons

Professional Organization and Committees:

• American Academy of Otolaryngology - Head and Neck Surgery
• 1990 - present Infectious Disease Committee
• 1990 – present Medical Devices and Drugs Committee (Chairman, 1993 - 1995)
• 1994 – present Program Advisory Committee
• 1998 – present Rhinology Committee
• 1999 – present Grants and Awards Committee
• 1999 – present Development Committee
• American College of Surgeons
• American Society for Microbiology

Honors and Awards:

• Faculty Teaching Award: Department of Pediatrics, Univ. of FL residents’ presentation, 1995
• Honor Award (for academic contributions): American Acad. of Otolaryngology - Head and Neck Surgery -1994

Medical School:

Michiko Kuno Research Award - 1981 (1st Prize - Student Research, UNC School of Medicine) "Edema production and albumen degradation by Vibrio vulnificus."

Deborah Leary Award - 1981 (1st Prize - Student Research Paper, UNC School of Medicine) "Experimental pathogenesis of Vibrio vulnificus infections."

Graduate School:

Teaching Assistantship. Department of Biology, University of North Carolina - Charlotte. 1976-77.

Undergraduate:

Full Athletic Grant-In Aid (Basketball) - Auburn University - 1970-71.

Editorial Positions:

• Infectious Disease Section Editor, Ear, Nose and Throat J.
• Editorial Board: Arch. Otolarynogology
• Editorial Board: Ann. Otol. Rhinol. Larynogology
• Editorial Board: Otolaryngology, Head & Neck Surgery
• Editorial Board: Head and Neck Surgery

National Panels and Committees:

• 2001 – Member, International “Antimicrobial Resistance Educational Program
• 2001 – Director and Chair of national training program: “Improving Outcomes in Sinusitis”
• 2000 – Co-author: National Guidelines for Antimicrobial Therapy of Acute Bacterial Rhinosinusitis
• 1999 – present: Member, sinus coalition and CDC committee on anitibiotics in sinusitis
• 1999 – AAO-HNS Consensus Committee on antibiotic resistance and ototopical agents.
• 1998 – 2001: Co-chairman and organizer, National Otitis Media Education

Workshop Program (> 100 3.5 hrs CME programs in US per year)

• 1999 – present: CDC committee on Sinusitis – Impact of Drug Resistance
• 1996 - NIH sponsored consensus panel on Sinusitis (Joint Panel from AAO-HNS, AAAAI, and Pediatrics
• 1995 - present: Centers for Disease Control and Prevention “working group on therapy of drug resistant pneumococci”
• 1995 - present: Otolaryngology Advisory Panel Member, FDA and U.S. Pharmacopia

Private industry consultant for new and existing antimicrobial development:

• Glaxo SmithKline
• Ortho-McNeil
• Bristol-Myers Squibb
• Daiichi Corporation
• Bayer Laboratories
• Ono Pharmaceuticals
• Abbott Laboratories
• Aventis Pharmaceuticals

Military Background:

• 1971 - 1975 Active Duty - U.S. Army
• 1976 - 1986 Army National Guard
• 1986 - 1996 Army Reserve, Active

Military Awards, Achievements and Duty Positions:

• Basic Combat Training (1971) - Distinguished Honor Graduate
• NCO Course (1972) - Honor Graduate
• Infantry Officer Candidate School (1973) - Distinguished Honor Graduate
• Airborne Training - 1973
• Ranger Training - 1973
• Air Defense Officer Basic Course - 1973
• Chaparral/Vulcan Officer Course - 1973
• Nuclear, Biological, Chemical Officer Course (1973) - Distinguished Honor Graduate
• The Outstanding Junior Officer Leadership Award (Ft. Bragg) - 1974
• 82nd Airborne Division Platoon Leader and Executive Officer - 1973-75
• Medical Platoon Leader, (Mechanized Infantry), NC Army National Guard 1977-83
• Chief Tactics Committee, North Carolina Military Academy - 1980-82
• Commander, 105th Medical Detachment (TM OA), NCARNG - 1983-86
• Projects Officer, 818th Hospital Center, Ft. Gillam, GA, USAR - 1986-1987
• Operations & Training Officer, [301st Field Hospital, USAR, Gainesville, FL] 1987 - 1992.
• Commander, Hospital Unit, [301st Field Hospital, USAR, Gainesville, FL] 1992 - 1993
• Commander, 1878th Head and Neck Surgical Team, Jacksonville, FL 1993 – 1996
• Inactive Reserve (retired) (rank: Lt. Colonel): 1996 - present

Administrative and Community Services:

• 2000 - Chairman, Dept. of Otolaryngology
• 1999 – 2000 Interim Chairman, Department of Otolaryngology
• 1999 - Chief of Otolaryngology, Memorial Herman Hospital
• 1999 - Chief of Otolaryngology, LBJ Hospital
• 1999 – 2000 Interim Chairman, Dept. of Otolaryngology
• 1999 - Medical Director, Univ. of Tx Ped. Surgery (multi-specialty) clinic
• 1997 - 1999 Residency Director, Department of Otolaryngology, Univ. of Texas - Houston
• 1997- Graduate Medical Education Committee, UT – Houston
• 1994 – 1996 Formulary Committee, Shands Hospital
• 1991 - 93 Chairman, Department of Surgery, Tallahassee Memorial Regional Medical Center
• 1987 - 94 Chairman, Infection Control Committee, Tallahassee Memorial Regional Medical Center
• 1985 - 86 Chief Resident, Otolaryngology
• 1985 -86 President, House Staff Council (Assoc.), North Carolina Memorial Hospital
• 1985 -86 Resident Representative and Member, Executive Council, North Carolina Memorial Hospital
• 1985 - 86 Member, Professional Liability Advisory Committee, North Carolina Memorial Hospital
• 1984 - 86 Coordinator, Emergency Room, Chatham Hospital, Inc., Siler City, North Carolina

Current Teaching Support (Univ. of Texas – Houston Medical School):

• 1996-01– Current Clinical and didactic instruction to residents and medical students in Otolarynology and Pediatrics
• ENT and Pediatric Grand Rounds ~ 2 X/yr.
• Pediatric, Family Medicine, Emergency Medicine teaching Conferences (~8 X/yr)
• Attending physician and teacher for student rotating on ENT
• 1996, 97, 98, 99, 2000 – Head and Neck Examination in 2d yr. Medical school course on physical diagnosis (2 hrs)

Current Grant Support:

• SmithKline Beecham: National Surveillance Program for resistance in respiratory pathogens.
• VLMed Publishing: Grant for editorial support, 1999, 2000, 2001
• Bayer Laboratories: Educational Grant 1999
• SmithKline Beecham: Augmentin ES for pediatric persistent otitis media, 1999
• Smith-Nephews Instrument Company: In vivo and in vitro evaluation of new tympanostomy tube designs
• Xomed Company: In vivo and in vitro evaluation of new tympanostomy tube designs

Past Grant Support:

• SmithKline Beecham: A new flouroquinolone in acute sinusitis, 1998-99
• GlaxoWellcome: Educational Grant, 1998
• Daiichi Corp: Unrestricted Grant, 1998
• Ortho-McNeil: Educational Grant, 1998SmithKline Beecham: Amoxicillin-clavulanate in chronic sinusitis, 1998
• Xomed Surgical Instruments: “Tympanostomy tube research center”: Evaluation of silver oxide coated tubes, 1997
• Support of Research Protocol: Efficacy of Ofloxacin Otic Solution and Augmentin Oral Suspension in the Treatment of Acute Purulent Otorrhea: Daiichi Pharmaceutical Corporation, 1996.
• Support of Research Protocol: Comparative Trial of cefpodoxime proxetil (5 days) with cefixime (10 days) for acute otitis media in children: Upjohn Corporation, 1994-95.
• Support of Researd Protocol: Efficacy of cefprozil, compared to amoxicillin-clavulanate for sinusitis: Bristol-Myers Laboratories, 1992-93.
• Basic Science Research Grant: NC Heart Association: Vibrio vulnificus hemocenration and shock. 1975-78.

See Dr. Poole's Publications & Articles